Medication Guides

Tirzepatide Dosage: A Complete Guide to Starting Doses, Titration, and Maintenance

GLP-1 Companion · 9 min read

Tirzepatide is a dual GIP/GLP-1 receptor agonist approved under the brand names Mounjaro (for type 2 diabetes) and Zepbound (for chronic weight management). It is administered as a once-weekly subcutaneous injection and follows a structured dose escalation schedule designed to minimize side effects while progressively increasing efficacy. This guide covers the complete dosage roadmap — from day one through maintenance.

Available Tirzepatide Doses

Tirzepatide is available in six pen strengths: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg. Each strength is color-coded and comes in a single-dose autoinjector pen. Mounjaro and Zepbound use identical drug concentrations — the difference is the FDA-approved indication, not the medication itself.

Standard Tirzepatide Dosage Titration Schedule

• Weeks 1–4: 2.5 mg once weekly (starting/introductory dose)
• Weeks 5–8: 5 mg once weekly (first increase)
• Weeks 9–12: 7.5 mg once weekly (second increase)
• Weeks 13–16: 10 mg once weekly (third increase)
• Weeks 17–20: 12.5 mg once weekly (fourth increase)
• Week 21 onward: 15 mg once weekly (maximum approved dose)

This standard schedule moves up every 4 weeks. In practice, your provider may slow the titration — for example, staying at 5 mg or 7.5 mg for 8 weeks instead of 4 — if you are experiencing significant side effects. Slower titration is associated with better tolerability and is not a sign that the medication is not working.

The Starting Dose: 2.5 mg

The 2.5 mg starting dose is intentionally sub-therapeutic. It is not expected to produce significant weight loss on its own. Its purpose is to allow your body to adjust to the drug's effects on gastric motility before moving to doses that have meaningful metabolic impact. Many patients feel little effect at 2.5 mg, which is normal and expected.

Maintenance Dosing: Finding Your Effective Dose

Not everyone needs to reach 15 mg. In clinical trials (SURMOUNT-1 for Zepbound, SURPASS for Mounjaro), meaningful and statistically robust weight loss and blood sugar improvements were seen at every dose level. Some patients find their "sweet spot" — where appetite is well controlled and side effects are minimal — at 10 mg or 12.5 mg and have no reason to increase further. Your provider should help you evaluate whether the additional efficacy of a higher dose justifies any increase in side effects.

Tirzepatide Dosage for Type 2 Diabetes (Mounjaro)

For Mounjaro used in diabetes management, the titration schedule is the same. The target dose for glycemic control is typically 5 mg–15 mg weekly, with dose adjustments guided by HbA1c response and tolerability. Patients on insulin or sulfonylureas require closer monitoring for hypoglycemia, particularly at higher doses.

Tirzepatide Dosage for Weight Loss (Zepbound)

For Zepbound in chronic weight management, the FDA-approved maintenance doses are 5 mg, 10 mg, and 15 mg weekly. In the SURMOUNT-1 trial, patients on 15 mg lost an average of 22.5% of body weight over 72 weeks — the highest weight loss seen in any randomized GLP-1 class trial at that time. Patients at 5 mg and 10 mg also had significant reductions, averaging 15% and 19.5% respectively.

How to Inject Tirzepatide

Tirzepatide is injected subcutaneously into the abdomen, upper thigh, or upper arm. Rotate injection sites each week to reduce the chance of skin irritation or lipohypertrophy (fatty lumps under the skin from repeated injections in the same spot). The autoinjector pen is designed for self-injection — pressing the button activates a spring-loaded needle that delivers the dose automatically.

What to Do if You Miss a Dose

If you miss a tirzepatide dose, the action depends on timing. If your missed dose is within 4 days (96 hours) of your scheduled injection day, take it as soon as you remember and continue on your usual weekly schedule. If more than 4 days have passed, skip the missed dose entirely and resume with your next scheduled dose. Never take two doses in one week to make up for a missed injection.

Managing Side Effects by Dose Level

Side effects are most pronounced at dose transition points. The jump from 5 mg to 7.5 mg and from 10 mg to 12.5 mg are commonly reported as the most challenging. At 7.5 mg and above, the dual GIP receptor activation becomes more clinically significant — some patients notice appetite suppression becomes very strong, requiring mindful eating to ensure adequate nutrition.

1. At 2.5 mg: Minimal side effects expected. Use this period to establish good eating habits — smaller portions, slower eating, no large meals.
2. At 5 mg: Nausea and appetite suppression increase meaningfully. This is where most patients first notice strong satiety signals.
3. At 7.5 mg–10 mg: GI side effects may increase again. Stick to low-fat, high-protein, fiber-rich meals. Avoid carbonated drinks.
4. At 12.5 mg–15 mg: Many patients report very strong fullness signals. Focus on nutrient density — getting adequate protein, vitamins, and minerals despite smaller food volumes.

Compound Tirzepatide: Dosage Notes

Compounded tirzepatide is available from some specialty pharmacies and telehealth providers, particularly when brand-name Mounjaro or Zepbound is in shortage or unaffordable. Compounded versions may use different concentration formats (mg/mL) and require patients to draw up doses with a syringe. Dosing milestones are the same, but the administration method differs. Always confirm dose calculations carefully with your provider if using compounded tirzepatide.

When to Talk to Your Doctor About Your Dose

• If you experience severe or persistent nausea, vomiting, or diarrhea — a slower titration may be appropriate.
• If weight loss has stalled for 8+ weeks — your provider may recommend increasing the dose or evaluating other factors.
• If side effects at a dose are manageable but not resolved — you may benefit from staying at the current dose for an extra 4 weeks before increasing.
• If you have achieved your weight or glucose goals — maintenance at a lower dose may be discussed.

The Bottom Line

Tirzepatide's structured titration schedule exists for good reason — it allows your body to adapt gradually, reducing the severity and duration of side effects. The 2.5 mg starting dose is not where results happen; meaningful benefits emerge between 5 mg and 15 mg over the course of several months. Patience with the titration process, combined with dietary adjustments and close communication with your provider, gives you the best chance of staying on treatment and reaching your goals.

Sources

• Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). NEJM, 2022.
• FDA Prescribing Information — Zepbound (tirzepatide) injection, 2023.
• Frías JP et al. Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes (SURPASS-2). NEJM, 2021.